Elan Q3 revenue contracts

Drug maker Elan posted a 2% fall in revenue for the quarter ended September 30, with total revenue of $281.4m (€203.6m) for Q3 2010 down on the figure of $287m (€207m) for the same period last year.

The company nonetheless said it was "very pleased" with the quarterly figures.